PKM and neoplasm: In line with our study, the pyruvate kinase M2 (PKM2) catalyzing the formation of pyruvate from phosphoenolpyruvate in the last step of glycolysis [34], was a potential serum biomarker for promoting tumor progression in lung cancer cells and patients [35].